{"id":"https://openalex.org/W2013569100","doi":"https://doi.org/10.1097/00001432-200202000-00004","title":"Pros and cons of therapeutic drug monitoring of antiretroviral agents","display_name":"Pros and cons of therapeutic drug monitoring of antiretroviral agents","alternate_titles":[],"publication_year":2002,"publication_date":"2002-02-01","ids":{"openalex":"https://openalex.org/W2013569100","doi":"https://doi.org/10.1097/00001432-200202000-00004","mag":"2013569100","pmid":"https://pubmed.ncbi.nlm.nih.gov/11964901"},"language":"en","primary_location":{"id":"doi:10.1097/00001432-200202000-00004","doi":"https://doi.org/10.1097/00001432-200202000-00004","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00001432-200202000-00004","pdf_url":null,"source":{"id":"https://openalex.org/S67076826","display_name":"Current Opinion in Infectious Diseases","issn_l":"0951-7375","issn":["0951-7375","1080-7861","1473-6527"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Opinion in Infectious Diseases","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2013569100"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5021568119","display_name":"David Marinus Burger","orcid":"https://orcid.org/0000-0001-7279-2818","observed_orcids":["https://orcid.org/0000-0001-7279-2818"]},"institutions":[{"id":"https://openalex.org/I2802934949","display_name":"Radboud University Medical Center","ror":"https://ror.org/05wg1m734","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2802934949"]}],"countries":["NL"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"David M. Burger","raw_affiliation_strings":["Department of Clinical Pharmacy, University Medical Centre Nijmegen, Geert Grooteplein 8, 6525 GA Nijmegen, The Netherlands. D.Burger@klinfarm.azn.nl","Department of Clinical Pharmacy, University Medical Centre Nijmegen, The Netherlands","TDM: therapeutic drug monitoring","e-mail: [email\u00a0protected]","fax +31 24 354 0331","to Dr David M. Burger PharmD, PhD, Department of Clinical Pharmacy, University Medical Centre Nijmegen, Geert Grooteplein 8, 6525 GA Nijmegen, The Netherlands. Tel: +31 24 361 6405"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Pharmacy, University Medical Centre Nijmegen, Geert Grooteplein 8, 6525 GA Nijmegen, The Netherlands. D.Burger@klinfarm.azn.nl","institution_ids":["https://openalex.org/I2802934949"]},{"raw_affiliation_string":"Department of Clinical Pharmacy, University Medical Centre Nijmegen, The Netherlands","institution_ids":[]},{"raw_affiliation_string":"TDM: therapeutic drug monitoring","institution_ids":[]},{"raw_affiliation_string":"e-mail: [email\u00a0protected]","institution_ids":[]},{"raw_affiliation_string":"fax +31 24 354 0331","institution_ids":[]},{"raw_affiliation_string":"to Dr David M. Burger PharmD, PhD, Department of Clinical Pharmacy, University Medical Centre Nijmegen, Geert Grooteplein 8, 6525 GA Nijmegen, The Netherlands. Tel: +31 24 361 6405","institution_ids":["https://openalex.org/I2802934949"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078789624","display_name":"Rob E. Aarnoutse","orcid":"https://orcid.org/0000-0001-8925-969X","observed_orcids":["https://orcid.org/0000-0001-8925-969X"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Rob E. Aarnoutse","raw_affiliation_strings":["Department of Clinical Pharmacy, University Medical Centre Nijmegen, The Netherlands","TDM: therapeutic drug monitoring"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Pharmacy, University Medical Centre Nijmegen, The Netherlands","institution_ids":[]},{"raw_affiliation_string":"TDM: therapeutic drug monitoring","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5073785042","display_name":"Patricia W. H. Hugen","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Patricia W.H. Hugen","raw_affiliation_strings":["Department of Clinical Pharmacy, University Medical Centre Nijmegen, The Netherlands","TDM: therapeutic drug monitoring"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Pharmacy, University Medical Centre Nijmegen, The Netherlands","institution_ids":[]},{"raw_affiliation_string":"TDM: therapeutic drug monitoring","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5021568119"],"corresponding_institution_ids":["https://openalex.org/I2802934949"],"apc_list":null,"apc_paid":null,"fwci":4.4772,"has_fulltext":false,"cited_by_count":40,"citation_normalized_percentile":{"value":0.94715722,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":92},"biblio":{"volume":"15","issue":"1","first_page":"17","last_page":"22"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.9901999831199646,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.9901999831199646,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10082","display_name":"HIV/AIDS Research and Interventions","score":0.005100000184029341,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/therapeutic-drug-monitoring","display_name":"therapeutic drug monitoring","score":1.0},{"id":"https://openalex.org/keywords/antiretroviral-drugs","display_name":"antiretroviral drugs","score":0.9570000171661377},{"id":"https://openalex.org/keywords/hiv-infection","display_name":"HIV infection","score":0.9980000257492065},{"id":"https://openalex.org/keywords/protease-inhibitors","display_name":"protease inhibitors","score":0.9929999709129333},{"id":"https://openalex.org/keywords/non-nucleoside-reverse-transcriptase-inhibitors","display_name":"non-nucleoside reverse transcriptase inhibitors","score":1.0},{"id":"https://openalex.org/keywords/plasma-drug-concentration","display_name":"plasma drug concentration","score":0.9309999942779541},{"id":"https://openalex.org/keywords/antiviral-response","display_name":"antiviral response","score":0.8510000109672546},{"id":"https://openalex.org/keywords/drug-toxicity","display_name":"drug toxicity","score":0.9100000262260437},{"id":"https://openalex.org/keywords/interpatient-variability","display_name":"interpatient variability","score":0.9539999961853027},{"id":"https://openalex.org/keywords/treatment-adherence","display_name":"medication adherence","score":0.7710000276565552}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9355729222297668},{"id":"https://openalex.org/C2780272996","wikidata":"https://www.wikidata.org/wiki/Q1261151","display_name":"Therapeutic drug monitoring","level":3,"score":0.8493125438690186},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.7474339604377747},{"id":"https://openalex.org/C19831878","wikidata":"https://www.wikidata.org/wiki/Q659446","display_name":"Therapeutic index","level":3,"score":0.592769980430603},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.5706243515014648},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5377827286720276},{"id":"https://openalex.org/C2781143361","wikidata":"https://www.wikidata.org/wiki/Q55761529","display_name":"Protease inhibitor (pharmacology)","level":5,"score":0.49238860607147217},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.4896584153175354},{"id":"https://openalex.org/C2993143319","wikidata":"https://www.wikidata.org/wiki/Q583050","display_name":"Antiretroviral therapy","level":4,"score":0.44500282406806946},{"id":"https://openalex.org/C2776714187","wikidata":"https://www.wikidata.org/wiki/Q212410","display_name":"Protease","level":3,"score":0.44271767139434814},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.24865123629570007},{"id":"https://openalex.org/C142462285","wikidata":"https://www.wikidata.org/wiki/Q2528140","display_name":"Viral load","level":3,"score":0.17327740788459778},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.0},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D006678","descriptor_name":"HIV","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D006678","descriptor_name":"HIV","qualifier_ui":"Q000302","qualifier_name":"isolation & purification","is_major_topic":false},{"descriptor_ui":"D006678","descriptor_name":"HIV","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010349","descriptor_name":"Patient Compliance","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012367","descriptor_name":"RNA, Viral","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D012367","descriptor_name":"RNA, Viral","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D016903","descriptor_name":"Drug Monitoring","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D019380","descriptor_name":"Anti-HIV Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D019380","descriptor_name":"Anti-HIV Agents","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D019380","descriptor_name":"Anti-HIV Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D019380","descriptor_name":"Anti-HIV Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1097/00001432-200202000-00004","doi":"https://doi.org/10.1097/00001432-200202000-00004","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00001432-200202000-00004","pdf_url":null,"source":{"id":"https://openalex.org/S67076826","display_name":"Current Opinion in Infectious Diseases","issn_l":"0951-7375","issn":["0951-7375","1080-7861","1473-6527"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Opinion in Infectious Diseases","raw_type":"journal-article"},{"id":"pmid:11964901","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11964901","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current opinion in infectious diseases","raw_type":"Journal Article"},{"id":"pmh:oai:repository.ubn.ru.nl:2066/119505","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/2066/119505","pdf_url":null,"source":{"id":"https://openalex.org/S4306401067","display_name":"Radboud Repository (Radboud University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I145872427","host_organization_name":"Radboud University Nijmegen","host_organization_lineage":["https://openalex.org/I145872427"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Current Opinion in Infectious Diseases, 15, 1, pp. 17-22","raw_type":"Article / Letter to editor"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":20,"referenced_works":["https://openalex.org/W1985120639","https://openalex.org/W2008263033","https://openalex.org/W2008565853","https://openalex.org/W2013417313","https://openalex.org/W2028989559","https://openalex.org/W2038025308","https://openalex.org/W2039287713","https://openalex.org/W2043477103","https://openalex.org/W2046493152","https://openalex.org/W2051678628","https://openalex.org/W2073957045","https://openalex.org/W2079573278","https://openalex.org/W2080008894","https://openalex.org/W2106737113","https://openalex.org/W2127840648","https://openalex.org/W2135892517","https://openalex.org/W2164099498","https://openalex.org/W2165589438","https://openalex.org/W2318022415","https://openalex.org/W2330848975"],"related_works":["https://openalex.org/W2004182408","https://openalex.org/W2114354242","https://openalex.org/W2170561155","https://openalex.org/W1979933761","https://openalex.org/W2094960859","https://openalex.org/W2127096996","https://openalex.org/W2055552960","https://openalex.org/W7221264812","https://openalex.org/W2157656774","https://openalex.org/W2111873900"],"abstract_inverted_index":{"Therapeutic":[0],"drug":[1,25,44,56,78],"monitoring":[2,57,79],"has":[3],"the":[4,15],"promise":[5],"to":[6,67],"become":[7],"a":[8,62],"part":[9],"of":[10,17,27,38,76],"routine":[11],"patient":[12],"care":[13],"in":[14,80],"treatment":[16],"HIV":[18,81],"infection.":[19],"It":[20],"is":[21,51],"known":[22],"that":[23],"plasma":[24],"concentrations":[26],"protease":[28],"inhibitors":[29,34],"and":[30,64,74],"non-nucleoside":[31],"reverse":[32],"transcriptase":[33],"are":[35],"better":[36],"predictors":[37],"antiviral":[39],"response":[40],"or":[41],"toxicity":[42],"than":[43],"dose":[45],"is.":[46],"Furthermore,":[47],"high":[48],"interpatient":[49],"variability":[50],"significant.":[52],"In":[53],"addition,":[54],"therapeutic":[55,77],"may":[58],"be":[59],"used":[60],"as":[61],"direct":[63],"objective":[65],"instrument":[66],"measure":[68],"non-adherence.":[69],"This":[70],"review":[71],"describes":[72],"possibilities":[73],"limitations":[75],"treatment.":[82]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2013569100","counts_by_year":[{"year":2019,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
